Tanveer Ahmad

Employment

• INSERM Post-Doctoral Researcher
  2024 - Present
• Institut pour l'avancée des biosciences Post-Doctoral Researcher
  2020 - 2024
• Université de Strasbourg Post-Doctoral Researcher
  2020 - 2020

Education

• University of the Punjab Master's Biochemical Pharmacology
  2013 - 2015
• Bahauddin Zakariya University Pharm-D (Doctor of Pharmacy)
  2007 - 2013

Projects & Funding

Projects & funding information is unavailable.

Publications (8)

• Natural and Synthetic Anticancer Epidrugs Targeting the Epigenetic Integrator UHRF1
  Molecules 2023 DOI: 10.3390/molecules28165997
  +Save
• SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation–Phosphorylation Cross-talk
  Cancer Discovery 2022 DOI: 10.1158/2159-8290.CD-21-0205
  +Save
• Tannin extract from maritime pine bark exhibits anticancer properties by targeting the epigenetic UHRF1/DNMT1 tandem leading to the re-expression of TP73
  Food & Function 2022 DOI: 10.1039/D1FO01484F
  +Save
• Aberrant RNA methylation triggers recruitment of an alkylation repair complex
  Molecular Cell 2021 DOI: 10.1016/j.molcel.2021.09.024
  +Save
• TIP60 governs the auto‑ubiquitination of UHRF1 through USP7 dissociation from the UHRF1/USP7 complex.
  International journal of oncology 2021 DOI: 10.3892/ijo.2021.5269
  +Save
• A Molecular Tool Targeting the Base‐Flipping Activity of Human UHRF1
  Chemistry – A European Journal 2019 DOI: 10.1002/chem.201902605
  +Save
• Interaction of the epigenetic integrator UHRF1 with the MYST domain of TIP60 inside the cell.
  Journal of experimental & clinical cancer research : CR 2017 DOI: 10.1186/s13046-017-0659-1
  +Save
• The epigenetic integrator UHRF1: on the road to become a universal biomarker for cancer.
  Oncotarget 2017 DOI: 10.18632/oncotarget.17393
  +Save